The going-private merger has closed and shares have been cashed out at $16.50. No further trading or reporting obligations remain. Monitor for any potential appraisal rights or ancillary litigation, but the deregistration is effectively a non-event for current holders.
Price Chart
Executive Summary
Select Medical Holdings Corp filed Form 15-12G to terminate registration of its common stock under Section 12(g), effective July 13, 2026. This is the final procedural step following the take-private merger with an affiliate of Welsh, Carson, Anderson & Stowe completed on July 1, 2026, where each SEM share was converted into $16.50 cash. With only 13 holders of record remaining, deregistration is a routine administrative close-out of public reporting obligations.
Key Facts
- Form 15-12G terminates registration under Section 12(g) of the Exchange Act.
- Approximate number of holders of record as of filing date: thirteen.
- Filed on July 13, 2026, following the delisting (25-NSE) on July 1, 2026.
- Take-private merger with affiliate of Welsh, Carson, Anderson & Stowe closed July 1, 2026; SEM shareholders received $16.50 cash per share.
- Trading of SEM common stock was suspended on July 1, 2026.
Financial Impact
Routine final step after completed take-private at $16.50 per share, no incremental financial impact on remaining shareholders.
Risk Factors
- Minor risk of appraisal or dissenter rights claims from remaining holders, though unlikely given only 13 holders.
- No ongoing public disclosure; remaining holders may face liquidity challenges as stock will trade OTC (if at all).
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 15-12G Filing (Primary) | 0001104659-26-082845 |
| Document: 0001104659-26-082845-index-headers.html | 0001104659-26-082845 |
| Document: 0001104659-26-082845-index.html | 0001104659-26-082845 |
| Document: 0001104659-26-082845.txt | 0001104659-26-082845 |
Track record
8 reports on SEM
2 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +1.54% at T+60 after the Mar 3, 2026 report. 3 of 4 went positive at some point.
Filters
- Jul 13, 202618w ago 15-12G Neutral 4/10 Viewing No price data
- Jul 1, 202619w ago 25-NSE Neutral 9/10 Entry $16.52 No price data
- Jul 1, 202619w ago 8-K Bullish 8/10 Entry $16.52 No price data
- Jun 26, 202620w ago 8-K Bullish 7/10 Entry $16.53 No price data
- Apr 30, 202628w ago 8-K Bearish 6/10 Entry $16.38 to $16.51 ▼ −0.81% +4.45% vs SPY
- Apr 15, 202630w ago PREM14A Bullish 8/10 Entry $16.38 to $16.45 ▲ +0.43% −5.62% vs SPY
- Mar 4, 202636w ago DEFA14A Neutral 3/10 Entry $16.25 to $16.29 ▲ +0.25% +4.66% vs SPY
- Mar 3, 202636w ago DEFA14A Bullish 9/10 Entry $16.26 to $16.29 ▲ +0.18% +4.59% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers